Saint Luke's Newsroom
Nov. 17, 2021
TCTMD: Canagliflozin Improves Quality of Life in HF Patients
Treating heart failure patients with canagliflozin significantly improves quality of life, with the marked benefit observed early and sustained through follow-up, according to the results of the CHIEF-HF trial.
Medscape logo
Nov. 17, 2021
Medscape: Canagliflozin Improves HF Symptoms in Fully Remote Trial
New research reported at the AHA Scientific Sessions 2021 shows that the benefits of sodium-glucose cotransporter-2 (SGLT2) inhibitors on symptoms and quality of life in patients with heart failure extend to canagliflozin.
Nov. 10, 2021
KCTV: Tiny baby goes home, graduates from Saint Luke's NICU
Baby Julian was born prematurely at 22 weeks and 2 days and after 155 days he was able to go home with his family.
Nov. 9, 2021
tctMD: SURTAVI: Self-Expanding TAVI Valve Holds Up vs SAVR Through 5 Years
After 2 years, clinical outcomes were similar, hemodynamics favored TAVI, and paravalvular leak favored surgery.
Nov. 9, 2021
KMBC: Daylight saving time can signal the the start of seasonal mental health struggles
KMBC talked to a psychotherapist about ways to treat Seasonal Affective Disorder and thrive this time of year. 
Nov. 9, 2021
Healio: Lower ambulatory hemodynamic pressure correlates with improved HF symptom burden
Dr. Michael Nassif and colleagues found lower mean diastolic pulmonary artery pressure was associated with improvements in heart failure symptoms in a recent subanalysis.
Nov. 3, 2021
KSHB: Former Congressman Dennis Moore was advocate for Alzheimer's awareness
KSHB talked to Dr. Mignon Makos about how a new treatment for Alzheimer's could be a stepping stone to help patients with advanced Alzheimer's.
Nov. 2, 2021
Kansas City Star: Saint Luke's reaches nearly 100% compliance with COVID-19 employee vaccination mandate
Saint Luke’s Health System has reached nearly 100% compliance with its COVID-19 vaccination mandate for employees.
Nov. 2, 2021
Medicine Matters: PRESERVED-HF: Support for dapagliflozin to improve HFpEF health status
Mikhail Kosiborod, MD, talks with Medicine Matters about the PRESERVED-HF trail from Saint Luke's Mid America Heart Institute.